Genes & biomarkers

NRAS variants

NRAS · RAS pathway

A biomarker may help rule out a treatment as well as select one.

Sources checked · Introductory guide

On this page

What does this result mean?

NRAS belongs to the same signaling family as KRAS. Variants can occur in colorectal cancer and melanoma; NRAS results should be checked separately from KRAS.[1]

How does it connect to treatment?

In metastatic colorectal cancer, RAS variants including NRAS help identify tumors unlikely to benefit from anti-EGFR treatment such as cetuximab. This rule is not identical for every cancer type.[2]

What should I check in my report?

Ask whether “RAS wild type” reflects testing of the required regions of both KRAS and NRAS. An NRAS finding alone does not select a specific direct inhibitor.

Questions for your care team

  • How does my NRAS result affect anti-EGFR treatment?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. MedlinePlus Genetics · NRAS (opens in a new tab)
  2. MHRA · Cetuximab: RAS testing (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

NRAS variants | Cancer Encyclopedia | My Chemo Diary